Workforce Diversity and Organizational Performance during COVID-19: Evidence from Pharmaceutical Companies

  • Junejo I
  • Shaikh S
  • Thebo J
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study is to identify the impact of workforce diversity on organizational performance. For achieving research objectives and testing hypothesis the primary data collected with help of adopted questionnaire. The respondents were considered from Pharmaceutical companies which are operating in Sindh, Pakistan. Sample was consisting of 300. Findings of this study confirmed all proposed hypothesis are found to have significant impact of Gender diversity during covid-19, Age diversity during covid-19, Education diversity during covid-19 and Experience diversity during covid-19 on Organizational performance during covid-19 in pharmaceutical companies. However, new insights of this study revealed that gender diversity during covid-19 has more positive and significant impact with respect to other workforce diversity variables due to higher beta value. For better future performance this study results suggest to top management of Pharmaceutical companies should manage the workforce diversity.

Cite

CITATION STYLE

APA

Junejo, I., Shaikh, S., Thebo, J. A., & Salahuddin, S. (2021). Workforce Diversity and Organizational Performance during COVID-19: Evidence from Pharmaceutical Companies. Journal of Pharmaceutical Research International, 801–808. https://doi.org/10.9734/jpri/2021/v33i60a34550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free